Clinical Trial Update: Pivotal Trial of Dermagraft(R) to Treat Diabetic Foot Ulcers [Phase 3]

View source ↗

Summary

A pivotal Phase 3 trial evaluating Dermagraft for diabetic foot ulcers has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diabetic Foot Ulcer

Drugs mentioned

• Dermagraft (human fibroblast-derived dermal substitute)

Snippet

Sponsor: Organogenesis | Conditions: Diabetic Foot Ulcer | Phase 3 | Status: COMPLETED